Inscobee Amends Paid-in Capital Increase Details
인스코비
006490
Signal Score
Historical Avg Return (5d)
+0.26%
Data Coverage
100%n=2457
Risk-adjusted indicator based on 2457 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEGATIVE
Key Numbers
- • Total Capital Increase: 5.00B KRW (Amended from 7.572B KRW)
- • New Shares Issued: 10,000,000 Shares
- • Issuance Price per Share: 500 KRW (Par Value)
- • Funds for Operations: 2.428B KRW (Amended from 5.00B KRW)
- • Funds for Debt Repayment: 2.572B KRW (Amended from 2.572B KRW)
AI Analysis Summary
Inscobee, Inc. announced an amendment to its paid-in capital increase, reducing the total funding from 7.572B KRW to 5.00B KRW. The purpose of the funds has been reallocated to 2.428B KRW for operations and 2.572B KRW for debt repayment, specifically for early redemption of 32nd, 35th, and 36th convertible bonds. 10,000,000 new shares will be issued at 500 KRW per share (par value) to Nemo Bio Ventures. The new shares will be subject to a one-year lock-up period. This capital increase, while providing necessary funds, will dilute existing shareholder value.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.